Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference
Madrigal Pharmaceuticals (Nasdaq: MDGL) has announced its participation in the upcoming 45th Annual TD Cowen Health Care Conference. The company's presentation is scheduled for Tuesday, March 4, 2025, at 11:10 A.M. ET.
The event will feature a live webcast accessible through a direct link or via Madrigal's Investor Relations Events page. For those unable to attend the live presentation, a replay option will be made available following the event.
Madrigal Pharmaceuticals (Nasdaq: MDGL) ha annunciato la sua partecipazione alla prossima 45ª Conferenza Annuale TD Cowen sulla Salute. La presentazione dell'azienda è programmata per martedì 4 marzo 2025, alle 11:10 A.M. ET.
L'evento presenterà una diretta web accessibile tramite un link diretto o attraverso la pagina Eventi delle Relazioni con gli Investitori di Madrigal. Per coloro che non possono partecipare alla presentazione dal vivo, sarà disponibile un'opzione di replica dopo l'evento.
Madrigal Pharmaceuticals (Nasdaq: MDGL) ha anunciado su participación en la próxima 45ª Conferencia Anual de Salud TD Cowen. La presentación de la empresa está programada para el martes 4 de marzo de 2025, a las 11:10 A.M. ET.
El evento contará con una transmisión en vivo accesible a través de un enlace directo o a través de la página de Eventos de Relaciones con Inversores de Madrigal. Para aquellos que no puedan asistir a la presentación en vivo, se ofrecerá una opción de repetición después del evento.
마드리갈 제약(Madrigal Pharmaceuticals) (Nasdaq: MDGL)이 다가오는 제45회 연례 TD Cowen 건강 관리 컨퍼런스에 참여한다고 발표했습니다. 회사의 발표는 2025년 3월 4일 화요일 오전 11시 10분 ET로 예정되어 있습니다.
이 이벤트는 직접 링크 또는 마드리갈의 투자자 관계 이벤트 페이지를 통해 액세스할 수 있는 라이브 웹캐스트를 제공합니다. 라이브 발표에 참석할 수 없는 분들을 위해 이벤트 후 재생 옵션이 제공될 예정입니다.
Madrigal Pharmaceuticals (Nasdaq: MDGL) a annoncé sa participation à la prochaine 45e Conférence Annuelle TD Cowen sur la Santé. La présentation de l'entreprise est prévue pour mardi 4 mars 2025, à 11h10 ET.
L'événement comprendra une diffusion en direct accessible via un lien direct ou via la page Événements des Relations avec les Investisseurs de Madrigal. Pour ceux qui ne peuvent pas assister à la présentation en direct, une option de rediffusion sera mise à disposition après l'événement.
Madrigal Pharmaceuticals (Nasdaq: MDGL) hat seine Teilnahme an der bevorstehenden 45. jährlichen TD Cowen Gesundheitskonferenz angekündigt. Die Präsentation des Unternehmens ist für Dienstag, den 4. März 2025, um 11:10 Uhr ET geplant.
Die Veranstaltung wird einen Live-Stream bieten, der über einen direkten Link oder über die Investor Relations-Eventseite von Madrigal zugänglich ist. Für diejenigen, die nicht an der Live-Präsentation teilnehmen können, wird nach der Veranstaltung eine Wiederholungsoption zur Verfügung stehen.
- None.
- None.
CONSHOHOCKEN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the 45th Annual TD Cowen Health Care Conference on Tuesday, March 4, 2025 at 11:10 A.M. ET.
The presentation will be webcast live and may be accessed here or by visiting Madrigal’s Investor Relations Events page. A replay of the webcast will be available after the event.
About Madrigal Pharmaceuticals
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. For more information, visit www.madrigalpharma.com.
Investor Contact
Tina Ventura, IR@madrigalpharma.com
Media Contact
Christopher Frates, media@madrigalpharma.com
FAQ
When is Madrigal Pharmaceuticals (MDGL) presenting at the TD Cowen Health Care Conference 2025?
How can investors watch Madrigal Pharmaceuticals' (MDGL) presentation at the TD Cowen conference?
Which healthcare conference is Madrigal Pharmaceuticals (MDGL) participating in March 2025?
Will there be a replay available of Madrigal Pharmaceuticals' (MDGL) TD Cowen conference presentation?
